India’s drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI. “Subject Expert Committee (SEC) is expected to meet this week and will review the data. However, final approval […]
Read Time : 1 Minutes
DGCI approves emergency use of Zydus Cadila’s Virafin for COVID-19
On Friday 23 April Drugs Controller General of India (DGCI) approved the emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults. According to Cadila Health, one dose of Pegylated Interferon Alpha-2b, ‘Virafin’ showed clinical and virological improvement in moderate COVID-19 cases. The Ahmedabad-based […]